Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

31.19
Delayed Data
As of Dec 07
 -0.37 / -1.17%
Today’s Change
28.25
Today|||52-Week Range
37.39
-3.38%
Year-to-Date
Big pharma should beware bite of small watchdogs
Dec 07 / FT.com - Paid Partner Content
Frontrunning: December 7
Dec 07 / Investing Channel - Paid Partner Content
Pfizer at the Mercy of Trump's Tweets: More Squawk From Jim Cramer
Dec 07 / TheStreet.com - Paid Partner Content
Better Buy: Amgen Inc. vs. Pfizer
Dec 07 / MotleyFool.com - Paid Partner Content
Trump warns Wall Street: I'm going to cut drug prices
Dec 07 / CNNMoney.com
Longest Winning Streak For Global Stocks On Monte Paschi Bailout Hopes, ECB Optimism
Dec 07 / Investing Channel - Paid Partner Content
Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study
Dec 07 / Zacks.com - Paid Partner Content
Pfizer Takes $106 Million Fine from U.K. for Price Hike of Epilepsy Drug
Dec 07 / TheStreet.com - Paid Partner Content
Is Pfizer's New PD-L1 Drug a Game-Changer?
Dec 07 / MotleyFool.com - Paid Partner Content
Pfizer fined 84m for charging 'unfair' price for epilepsy drug
Dec 07 / FT.com - Paid Partner Content

Today’s Trading

Previous close31.56
Today’s open31.33
Day’s range30.61 - 31.33
Volume44,053,675
Average volume (3 months)23,590,391
Market cap$191.5B
Dividend yield3.85%
Data as of 4:01pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)-21.24%
Earnings growth (this year)+9.99%
Earnings growth (next 5 years)+6.50%
Revenue growth (last year)-1.52%
P/E ratio31.2
Price/Sales4.13
Price/Book3.01

Competitors

 Today’s
change
Today’s
% change
MRKMerck-0.22-0.36%
NVSNovartis-0.34-0.49%
SNYSanofi-0.14-0.34%
ABBVAbbVie-1.63-2.65%
Data as of 4:02pm ET, 12/07/2016

Financials

Next reporting dateJanuary 31, 2017
EPS forecast (this quarter)$0.50
Annual revenue (last year)$48.9B
Annual profit (last year)$7.0B
Net profit margin14.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts


Search for Jobs